17 Jan 2020 07:00
17 January 2020
The Barkby Group PLC
("Barkby" or the "Company")
Exchange of Contracts at Huntingdon, Cambridgeshire
The Barkby Group PLC, the diversified business group, is pleased to announce the site in Huntingdon, Cambridgeshire referred to in the Company's AIM Admission Document dated 19 December 2020 has progressed from being in legal negotiations to having exchanged contracts.
It is proposed that the Company will develop a 43,410 sq. ft. mixed-use development trade and retail scheme, with a national builders merchant anchoring the site. Under the proposed development the Huntingdon site has an estimated gross development value of £10.7 million.
Charles Dickson, Executive Chairman of The Barkby Group Plc, commented:
"I am delighted to have exchanged contracts for this site in Huntingdon. The site is well positioned to benefit from the development and economic growth of the Oxford Cambridge Corridor. We are seeing strong demand from both the retail and employment sectors and pre-lets will be secured before work starts on site."
Enquiries:
The Barkby Group plc Charles Dickson (Executive Chairman)
| via Camarco |
finnCap Ltd (Nomad and Broker) Carl Holmes/Simon Hicks (corporate finance) Tim Redfern/Richard Chambers (ECM)
| +44 (0) 20 7220 0500 |
Camarco (Financial PR) Jennifer Renwick/Jane Glover | +44 (0) 20 3757 4994 |
Notes to editors
The Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses within Barkby include; Commercial Property Development, Barkby Hospitality (comprising Barkby Pubs and Workshop Coffee) and Centurian Automotive.
In addition to these businesses, Barkby has the right to participate in the upcoming fundraisings for two disruptive high growth private companies: Transcend Packaging, a sustainable and innovative paper packaging manufacturer aiming to eliminate single use plastic, and VivoPlex, a digital health company aiming to transform fertility treatment with precision medicine.
Barkby's strategy is to accelerate and maximise opportunities within its existing businesses as well as continue to source and invest in cash generative, growth businesses with the ability to disrupt.